Circulating soluble Fas levels in patients with hepatitis C virus infection and interferon therapy

Yoshimi Kakiuchi,Nobukazu Yuki,Kenya Iyoda,Yasunori Sugiyasu,Akira Kaneko,Michio Kato

Circulating soluble Fas levels in patients with hepatitis C virus infection and interferon therapy

2004

Yoshimi Kakiuchi
Nobukazu Yuki
Kenya Iyoda
Yasunori Sugiyasu
Akira Kaneko
Michio Kato

Background The clinical relevance of the circulating soluble form of the Fas-Receptor (sFas) was investigated in patients with hepatitis C receiving type 1 interferon (IFN) therapy.

Keywords:

Hepatitis C virus
Hepatitis C
Infection control
Clinical significance
Liver injury
Virology
Immunology
Apoptosis
Interferon
Medicine
Diabetes mellitus
Hepatology
in patient
Surgical oncology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations